120 related articles for article (PubMed ID: 14517486)
1. Poly-L-histidine downregulates fibrinolysis.
Chu AJ; Mathews ST
Blood Coagul Fibrinolysis; 2003 Oct; 14(7):627-32. PubMed ID: 14517486
[TBL] [Abstract][Full Text] [Related]
2. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro.
Horne MK; Goad JL; Merryman PK; Cullinane AM
Thromb Res; 2000 Jul; 99(2):179-86. PubMed ID: 10946092
[TBL] [Abstract][Full Text] [Related]
5. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
Suenson E; Lützen O; Thorsen S
Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
[TBL] [Abstract][Full Text] [Related]
6. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-induced fibrin clot lysis and its inhibition by plasma.
Carlin G
Ups J Med Sci; 1980; 85(1):29-33. PubMed ID: 6446181
[TBL] [Abstract][Full Text] [Related]
8. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
10. uPA-mediated plasminogen activation is enhanced by polyphosphate.
Whyte CS; Mutch NJ
Haematologica; 2021 Feb; 106(2):522-531. PubMed ID: 32029503
[TBL] [Abstract][Full Text] [Related]
11. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
Carr ME; Alving BM
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
[TBL] [Abstract][Full Text] [Related]
12. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
[TBL] [Abstract][Full Text] [Related]
14. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.
Mutch NJ; Engel R; Uitte de Willige S; Philippou H; Ariëns RA
Blood; 2010 May; 115(19):3980-8. PubMed ID: 20228273
[TBL] [Abstract][Full Text] [Related]
15. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
16. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
Lijnen HR; Dewerchin M; De Cock F; Collen D
Thromb Res; 1990 Feb; 57(3):333-42. PubMed ID: 2107593
[TBL] [Abstract][Full Text] [Related]
17. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
Lee KN; Jackson KW; McKee PA
Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
[TBL] [Abstract][Full Text] [Related]
18. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
19. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
Suenson E; Thorsen S
Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
